Shandong Keyuan Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 445.94 million compared to CNY 442.31 million a year ago. Revenue was CNY 447.58 million compared to CNY 442.87 million a year ago.

Net income was CNY 77.04 million compared to CNY 91.28 million a year ago. Basic earnings per share from continuing operations was CNY 0.76 compared to CNY 1.12 a year ago. Diluted earnings per share from continuing operations was CNY 0.76 compared to CNY 1.12 a year ago.